Back to today’s briefing

Story perspectives

Breakthrough Immunotherapy for Deadly Fungal Infection Unveiled

4/3/2025

44 8

Summary

Story summary

At the Lundquist Institute, a groundbreaking immunotherapy for mucormycosis is in the works, spearheaded by Dr. Ashraf S. Ibrahim. This severe fungal infection poses a grave threat to immunocompromised patients, with about 4,000 cases reported annually in the U.S. and even more in regions like India. The team is focused on proving the treatment's safety and effectiveness.

1 of 1

Story summary

At the Lundquist Institute, a groundbreaking immunotherapy for mucormycosis is in the works, spearheaded by Dr. Ashraf S. Ibrahim. This severe fungal infection poses a grave threat to immunocompromised patients, with about 4,000 cases reported annually in the U.S. and even more in regions like India. The team is focused on proving the treatment's safety and effectiveness.